Venus Concept Inc
VERO1.760USD
-0.020-1.12%
收盘 12/24, 13:00（美东）报价延迟15分钟
3.27M总市值
亏损市盈率 TTM
关于 Venus Concept Inc 公司
Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.
Venus Concept Inc简介
公司代码VERO
公司名称Venus Concept Inc
上市日期Oct 12, 2017
CEODe Silva (Rajiv D)
员工数量292
证券类型Ordinary Share
年结日Oct 12
公司地址235 Yorkland Blvd Suite 900
城市TORONTO
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Canada
邮编M2J 4Y8
电话18778488430
网址https://www.venusconcept.com/en-uk/
公司代码VERO
上市日期Oct 12, 2017
CEODe Silva (Rajiv D)
Venus Concept Inc公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Stanley Tyler Hollmig, M.D.
Dr. Stanley Tyler Hollmig, M.D.
Independent Director
Independent Director
1.76K
--
Mr. Kirk Gunhus
Mr. Kirk Gunhus
Chief Revenue Officer
Chief Revenue Officer
1.64K
--
Mr. Ross J. Portaro
Mr. Ross J. Portaro
Executive Vice President - Commercial Strategy and Head - Venus Hair
Executive Vice President - Commercial Strategy and Head - Venus Hair
812.00
--
Mr. Keith J. Sullivan
Mr. Keith J. Sullivan
Independent Director
Independent Director
753.00
+0.13%
Ms. Anna Georgiadis
Ms. Anna Georgiadis
Chief Human Resources Officer
Chief Human Resources Officer
157.00
+0.64%
Mr. Michael Mandarello
Mr. Michael Mandarello
Chief Legal Officer, Head of Strategy & Operations
Chief Legal Officer, Head of Strategy & Operations
136.00
--
Ms. Melissa Kang, CPA
Ms. Melissa Kang, CPA
Chief Product Officer
Chief Product Officer
--
--
Ms. Louise M. Lacchin
Ms. Louise M. Lacchin
Independent Director
Independent Director
--
--
Mr. Scott Barry
Mr. Scott Barry
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Domenic Della Penna, CPA
Mr. Domenic Della Penna, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Stanley Tyler Hollmig, M.D.
Dr. Stanley Tyler Hollmig, M.D.
Independent Director
Independent Director
1.76K
--
Mr. Kirk Gunhus
Mr. Kirk Gunhus
Chief Revenue Officer
Chief Revenue Officer
1.64K
--
Mr. Ross J. Portaro
Mr. Ross J. Portaro
Executive Vice President - Commercial Strategy and Head - Venus Hair
Executive Vice President - Commercial Strategy and Head - Venus Hair
812.00
--
Mr. Keith J. Sullivan
Mr. Keith J. Sullivan
Independent Director
Independent Director
753.00
+0.13%
Ms. Anna Georgiadis
Ms. Anna Georgiadis
Chief Human Resources Officer
Chief Human Resources Officer
157.00
+0.64%
Mr. Michael Mandarello
Mr. Michael Mandarello
Chief Legal Officer, Head of Strategy & Operations
Chief Legal Officer, Head of Strategy & Operations
136.00
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
业务USD
名称
营收
占比
Products—Systems
7.94M
50.59%
Subscription—Systems
4.68M
29.83%
Products—Other
2.44M
15.57%
Services
628.00K
4.00%
地区USD
名称
营收
占比
United States
9.73M
61.99%
International
5.96M
38.01%
业务
地区
业务USD
名称
营收
占比
Products—Systems
7.94M
50.59%
Subscription—Systems
4.68M
29.83%
Products—Other
2.44M
15.57%
Services
628.00K
4.00%
股东统计
更新时间: 12月3日 周三
更新时间: 12月3日 周三
持股股东
股东类型
持股股东
持股股东
占比
Orca Capital GmbH
5.47%
EW Healthcare Partners
5.33%
HealthQuest Capital Management, L.P
2.22%
DRW Securities, LLC
1.60%
Madryn Asset Management, LP
0.55%
其他
84.84%
持股股东
持股股东
占比
Orca Capital GmbH
5.47%
EW Healthcare Partners
5.33%
HealthQuest Capital Management, L.P
2.22%
DRW Securities, LLC
1.60%
Madryn Asset Management, LP
0.55%
其他
84.84%
股东类型
持股股东
占比
Investment Advisor
7.60%
Venture Capital
7.54%
Individual Investor
0.82%
Private Equity
0.55%
Investment Advisor/Hedge Fund
0.33%
Hedge Fund
0.10%
Research Firm
0.04%
其他
83.01%
机构持股
更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
33
256.25K
13.78%
+62.51K
2025Q2
48
303.44K
16.32%
+73.80K
2025Q1
57
222.57K
25.52%
+13.74K
2024Q4
59
229.67K
34.82%
+28.01K
2024Q3
64
3.05M
44.61%
-537.66K
2024Q2
70
3.54M
52.45%
+304.55K
2024Q1
74
3.18M
52.95%
-445.34K
2023Q4
77
2.92M
53.20%
-420.44K
2023Q3
87
3.15M
119.91%
-295.52K
2023Q2
98
3.14M
119.96%
-1.42M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Orca Capital GmbH
101.75K
5.47%
+101.75K
--
Jun 06, 2025
EW Healthcare Partners
99.02K
5.33%
+3.00
+0.00%
Jun 30, 2025
HealthQuest Capital Management, L.P
41.19K
2.22%
--
--
Dec 31, 2024
Madryn Asset Management, LP
10.19K
0.55%
--
--
Sep 30, 2025
De Silva (Rajiv)
7.58K
0.41%
--
--
Apr 28, 2025
Tower Research Capital LLC
3.92K
0.21%
+2.14K
+120.03%
Jun 30, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
May 11, 2023
Merger
15→1
May 11, 2023
Merger
15→1
公告日期
类型
比率
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
May 11, 2023
Merger
15→1
May 11, 2023
Merger
15→1
May 11, 2023
Merger
15→1
May 11, 2023
Merger
15→1
常见问题
Venus Concept Inc的前五大股东是谁？
Venus Concept Inc 的前五大股东如下：
Orca Capital GmbH持有股份：101.75K，占总股份比例：5.47%。
EW Healthcare Partners持有股份：99.02K，占总股份比例：5.33%。
HealthQuest Capital Management, L.P持有股份：41.19K，占总股份比例：2.22%。
Madryn Asset Management, LP持有股份：10.19K，占总股份比例：0.55%。
De Silva (Rajiv)持有股份：7.58K，占总股份比例：0.41%。
Orca Capital GmbH持有股份：101.75K，占总股份比例：5.47%。
EW Healthcare Partners持有股份：99.02K，占总股份比例：5.33%。
HealthQuest Capital Management, L.P持有股份：41.19K，占总股份比例：2.22%。
Madryn Asset Management, LP持有股份：10.19K，占总股份比例：0.55%。
De Silva (Rajiv)持有股份：7.58K，占总股份比例：0.41%。
Venus Concept Inc的前三大股东类型是什么？
Venus Concept Inc 的前三大股东类型分别是：
Orca Capital GmbH
EW Healthcare Partners
HealthQuest Capital Management, L.P
Orca Capital GmbH
EW Healthcare Partners
HealthQuest Capital Management, L.P
有多少机构持有Venus Concept Inc(VERO)的股份？
截至2025Q3，共有33家机构持有Venus Concept Inc的股份，合计持有的股份价值约为256.25K，占公司总股份的13.78%。与2025Q2相比，机构持股有所增加，增幅为-2.54%。
哪个业务部门对Venus Concept Inc的收入贡献最大？
在FY2025Q2，Products—Systems业务部门对Venus Concept Inc的收入贡献最大，创收7.94M，占总收入的50.59%。
